Es gab 50 kürzliche Insider-Transaktionen für Interpace Biosciences, Inc. (IDXG), darunter 33 Käufe und 5 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $2.88M und die gesamten Insider-Verkäufe auf $19M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Mccarthy Christopher, 1315 Capital Ii, L.p., Ampersand 2018 Limited Partnership. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — IDXG
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-12-01 |
Mccarthy Christopher |
Chief Financial Officer |
Optionsausübung |
1,111 |
- |
- |
46,791 |
| 2024-10-11 |
1315 Capital Ii, L.p. |
10 Percent Owner |
Aktienrückgabe |
19,000 |
$6.00 |
$114K |
- |
| 2024-10-11 |
Ampersand 2018 Limited Partnership |
10 Percent Owner |
Aktienrückgabe |
28,000 |
$6.00 |
$168K |
- |
| 2024-07-27 |
Mccarthy Christopher |
Chief Financial Officer |
Optionsausübung |
15,112 |
- |
- |
45,680 |
| 2024-02-01 |
Mccarthy Christopher |
Chief Financial Officer |
RSU-Zuteilung |
10,000 |
- |
- |
45,644 |
| 2024-02-01 |
Mccarthy Christopher |
Chief Financial Officer |
Optionsausübung |
6,045 |
- |
- |
30,568 |
| 2024-01-31 |
Mccarthy Christopher |
Chief Financial Officer |
Optionsausübung |
7,556 |
- |
- |
24,523 |
| 2023-12-01 |
Mccarthy Christopher |
Chief Financial Officer |
Optionsausübung |
1,095 |
- |
- |
16,967 |
| 2023-07-31 |
Mccarthy Christopher |
Chief Financial Officer |
RSU-Zuteilung |
25,000 |
- |
- |
35,644 |
| 2023-07-31 |
Mccarthy Christopher |
Chief Financial Officer |
Optionsausübung |
7,556 |
- |
- |
15,872 |
| 2023-04-21 |
Mccarthy Christopher |
Principal Financial Officer |
Veräußerung |
5,000 |
- |
- |
- |
| 2022-02-01 |
Aggarwal Vijay |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-02-01 |
Aggarwal Vijay |
Director |
RSU-Zuteilung |
28,000 |
$5.04 |
$141.12K |
28,000 |
| 2021-05-21 |
Burnell Thomas W. |
President & CEO |
Informierter Kauf |
10,855 |
$8.68 |
$94.22K |
10,855 |
| 2021-03-10 |
Freeburg Thomas John |
Chief Financial Officer |
RSU-Zuteilung |
50,000 |
$6.00 |
$300K |
50,000 |
| 2021-03-01 |
Kamin Peter |
10 Percent Owner |
Informierter Kauf |
2,862 |
$3.08 |
$8.81K |
44,670 |
| 2021-02-26 |
Kamin Peter |
10 Percent Owner |
Informierter Kauf |
2,897 |
$3.17 |
$9.18K |
41,808 |
| 2021-02-18 |
Kamin Peter |
10 Percent Owner |
Unbekannt |
- |
- |
- |
44,670 |
| 2021-01-29 |
Gorman Robert J. |
Director |
RSU-Zuteilung |
12,438 |
$4.02 |
$50K |
18,759 |
| 2020-12-01 |
Stover Jack E |
Other: Former Officer and Director |
RSU-Zuteilung |
43,750 |
$6.00 |
$262.5K |
43,750 |
| 2020-12-01 |
Burnell Thomas W. |
President and CEO |
Unbekannt |
- |
- |
- |
- |
| 2020-12-01 |
Burnell Thomas W. |
President and CEO |
RSU-Zuteilung |
125,000 |
- |
- |
225,000 |
| 2020-07-29 |
Early James |
Other: Former Chief Financial Officer |
Optionsausübung (Verkauf) |
5,000 |
- |
- |
- |
| 2020-07-09 |
Sullivan Stephen J |
Director |
RSU-Zuteilung |
29,300 |
$5.21 |
$152.65K |
29,300 |
| 2020-07-09 |
Keegan Joseph D |
Director |
RSU-Zuteilung |
29,000 |
$5.21 |
$151.09K |
29,000 |
| 2020-07-09 |
Rocca Fortunato R. |
Director |
RSU-Zuteilung |
28,000 |
$5.21 |
$145.88K |
28,000 |
| 2020-07-09 |
Gorman Robert J. |
Director |
RSU-Zuteilung |
77,000 |
$5.21 |
$401.17K |
77,000 |
| 2020-03-12 |
Stover Jack E |
President and CEO |
RSU-Zuteilung |
7,188 |
- |
- |
30,271 |
| 2020-01-29 |
Early James |
Chief Financial Officer |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2020-01-29 |
Gorman Robert J. |
Director |
RSU-Zuteilung |
6,321 |
$7.91 |
$50K |
6,321 |
| 2020-01-29 |
Knechtel Fred S. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2020-01-29 |
Knechtel Fred S. |
Chief Financial Officer |
RSU-Zuteilung |
60,000 |
$7.91 |
$474.6K |
60,000 |
| 2020-01-22 |
Stover Jack E |
President and CEO |
RSU-Zuteilung |
35,000 |
$8.18 |
$286.3K |
35,000 |
| 2020-01-22 |
Richard Gregory |
Chief Commerical Officer |
RSU-Zuteilung |
7,500 |
$8.18 |
$61.35K |
7,500 |
| 2020-01-22 |
Rocca Fortunato R. |
Director |
Unbekannt |
- |
- |
- |
- |
| 2020-01-22 |
Stover Jack E |
President and CEO |
Unbekannt |
- |
- |
- |
- |
| 2020-01-22 |
Richard Gregory |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2020-01-15 |
Mccarthy Laurence |
Director |
Aktienrückgabe |
270 |
$8.00 |
$2.16K |
- |
| 2020-01-15 |
Ampersand 2018 Limited Partnership |
10 Percent Owner |
Aktienrückgabe |
270 |
$8.00 |
$2.16K |
- |
| 2020-01-15 |
Lev Eric B. |
Director |
Aktienrückgabe |
270 |
$8.00 |
$2.16K |
- |
| 2020-01-15 |
1315 Capital Ii, L.p. |
10 Percent Owner |
Veräußerung |
3,166,666 |
$6.00 |
$19M |
- |
| 2020-01-15 |
Chan Edward |
Director |
Unbekannt |
- |
- |
- |
- |
| 2019-10-17 |
Mccarthy Laurence |
Director |
Unbekannt |
33,750,000 |
$0.80 |
$27M |
- |
| 2019-10-17 |
Gorman Robert J. |
Director |
Unbekannt |
- |
- |
- |
- |
| 2019-10-16 |
Ampersand 2018 Limited Partnership |
10 Percent Owner |
RSU-Zuteilung |
130 |
$0.80 |
$104.00 |
270 |
| 2019-10-16 |
Lev Eric B. |
Director |
RSU-Zuteilung |
130 |
$0.80 |
$104.00 |
270 |
| 2019-10-10 |
Ampersand 2018 Limited Partnership |
10 Percent Owner |
Aktienrückgabe |
80 |
- |
- |
- |
| 2019-10-10 |
Lev Eric B. |
Director |
Aktienrückgabe |
80 |
- |
- |
- |
| 2019-07-15 |
Ampersand 2018 Limited Partnership |
10 Percent Owner |
Unbekannt |
- |
- |
- |
- |
| 2019-07-15 |
Lev Eric B. |
10 Percent Owner |
Unbekannt |
- |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall